Pneumonia in Older Persons

Loeb, Mark
November 2003
Clinical Infectious Diseases;11/15/2003, Vol. 37 Issue 10, p1335
Academic Journal
Community-acquired pneumonia (CAP) is an important threat to the health of older adults. Streptococcus pneumonia remains the most important cause of CAP. Risk factors for CAP include alcoholism, asthma, immunosuppression, chronic respiratory or cardiac disease, institutionalization, and increasing age. Residents of long-term care facilities—a distinct subpopulation of elderly people—are at particularly high risk for developing pneumonia. In this setting, swallowing difficulties, witnessed aspiration, and receipt of sedatives are potentially modifiable risk factors. The clinical presentation in elderly patients is characterized by a reduced prevalence of nonrespiratory symptoms. Few randomized, controlled trials of therapy exist for elderly persons living in the community or in a long-term care setting. Good evidence exists to support the annual administration of influenza vaccine to older adults. Although evidence in clinical trials differs from evidence in observational studies that demonstrate clear benefits associated with the polysaccharide pneumococcal vaccine in this population, the vaccine is recommended for adults aged


Related Articles

  • Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia. Cardoso, Maria Regina A.; Nascimento-Carvalho, Cristiana M.; Ferrero, Fernando; Berezin, Eitan N.; Ruvinsky, Raúl; Camargos, Paulo A. M.; Sant'Anna, Clemax C.; Brandileone, Maria Cristina C.; March, Maria de Fátima P.; Feris-Iglesias, Jesus; Maggi, Ruben S.; Benguigui, Yehuda // Archives of Disease in Childhood;Mar2008, Vol. 93 Issue 3, p221 

    Objective: To determine whether the presence of in vitro penicillin-resistant Streptococcus pneumoniae increases the risk of clinical failure in children hospitalised with severe pneumonia and treated with penicillin/ampicillin. Design: Multicentre, prospective, observational study. Setting: 12...

  • Placebo-Controlled Trials of Treatments for Community-Acquired Pneumonia: Review of the Literature and Discussion of Feasibility and Potential Value. Murphy, Timothy F. // Clinical Infectious Diseases;12/1/2008 Supplement 3, Vol. 47, pS145 

    Community-acquired pneumonia (CAP) has a broad range of clinical manifestations, from apparently self- limited illness to severe disease. This observation raises the question of whether to perform placebo-controlled trials involving patients with mild CAP to determine quantitatively the...

  • Correction: Vol. 21, No. 3.  // Emerging Infectious Diseases;Jul2015, Vol. 21 Issue 7, p1279 

    A correction to the article "Risk Factors for Death From Invasive Pneumococcal Disease, Europe, 2010" that was published in the journal in 2015 is presented.

  • Studying the burden of community-acquired pneumonia in adults aged ⩾50 years in primary health care: an observational study in rural Crete, Greece. Bertsias, Antonios; Tsiligianni, Ioanna G.; Duijker, George; Siafakas, Nikolaos; Lionis, Christos // Primary Care Respiratory Society UK;6/26/2014, p1 

    BACKGROUND: Community-acquired pneumonia (CAP) is a potentially life-threatening condition that often requires hospitalisation particularly in the elderly population or in patients with comorbidities. AIMS: The aims of this study were to estimate the CAP frequency and severity in a well-defined...

  • BOX 15-7 PNEUMONIA. Scanlon, Valerie C.; Sanders, Tina // Essentials of Anatomy & Physiology;Jan2007, p357 

    Information on pneumonia from Chapter 15 of the book "Essentials of Anatomy & Physiology," is presented. The most common bacteria that causes pneumonia is probably Streptococcus pneumoniae, which is said to be responsible for at least 500,000 cases of pneumonia every year in the U.S. Most cases...

  • Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: Clinical and microbiological characteristics in Taiwan, 2001-2008. Yi-Tsung Lin; Yuan-Yu Jeng; Te-Li Chen; Chang-Phone Fung // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p307 

    Background: Klebsiella pneumoniae is the major cause of community-acquired pyogenic infections in Taiwan. This retrospective study evaluated the clinical and microbiological characteristics of bacteremic community-acquired pneumonia due to K. pneumoniae in Taiwanese adults. Methods: The clinical...

  • Contribution of a Urinary Antigen Assay (Binax NOW) to the Early Diagnosis of Pneumococcal Pneumonia. Rosón, Beatriz; Fernández-Sabé, Nuria; Carratala, Jordi; Verdaguer, Ricard; Dorca, Jordi; Manresa, Frederic; Gudiol, Francesc // Clinical Infectious Diseases;1/15/2004, Vol. 38 Issue 2, p222 

    We evaluated the usefulness of a rapid urinary antigen test (Binax NOW; Binax) to detect Streptococcus pneumoniae for the early diagnosis of community-acquired pneumococcal pneumonia (PP) in 220 nonseverely immunosuppressed adults. We compared results of this test with those of sputum Gram...

  • Asthma increases pneumococcal risk.  // Pulse;5/28/2005, Vol. 65 Issue 21, p22 

    The article reports that asthma is an independent risk factor for invasive pneumococcal disease, according to a study published in the "New England Journal of Medicine."

  • Streptococcus pneumoniae carriage and salivary antibodies induced by pneumococcus in Vilnius preschool children. Mauricas, Mykolas; Petraitienė, Sigita; Kvietkauskaitė, Raimonda; Tamošiūnas, Vytas; Girkontaitė, Irutė; Usonis, Vytautas // Acta Medica Lituanica;2009, Vol. 16 Issue 3/4, p111 

    Background. Streptococcus pneumoniae (pneumococcus) is a potential respiratory pathogen causing high-risk diseases, particularly in young children. Otherwise, carriage of pneumococcus may be asymptomatic depending on the serotype and the immune system of the individual. The aim of this study was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics